Bills · 2019-2020 Regular Session
Relating to: informed consent regarding a certain abortion-inducing drug regimen and reporting requirements for induced abortions.
Abortion Drugs Health services department of — Health Hospitals and health care facilities Reports
- Introduced, stopped here
- Passes Senate, not reached
- Passes Assembly, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill requires certain information regarding an abortion-inducing drug
regimen to be provided to a woman that is planning to have an abortion induced by
the abortion-inducing drug regimen. This bill also adds to the information required
to be reported for induced abortions.
Informed consent
Under current law, a woman upon whom an abortion is to be performed or
induced must give voluntary and informed written consent to an abortion. Except
in a medical emergency, a woman's consent to an abortion is considered informed
only if, at least 24 hours before the abortion is performed or induced, the physician
or an assistant has, in person, orally provided the woman with certain information
and given to the woman certain written materials. If the pregnancy is the result of
sexual assault or incest, the 24-hour period, but not the provision of information,
may be waived or reduced under certain circumstances. This bill requires a
physician, as part of the information that must be provided, to inform the woman,
if she is considering or planning to have an abortion induced by an abortion-inducing
drug regimen that includes mifepristone, that the ingestion of the first drug in the
abortion-inducing drug regimen may not result in an immediate abortion and that,
if the woman changes her mind after ingesting the first drug, the woman may be able
to continue the pregnancy but time is of the essence and she should contact a
physician to discuss options or consult the information provided in the materials that
she is required to be given to locate a health care professional that can assist in
counteracting the effects of the drug. The bill requires the Department of Health
Services to include with the written materials that a woman considering an abortion
must be given materials that are designed to inform a woman about the possibilities
of continuing a pregnancy after ingesting an abortion-inducing drug including
contact information for resources and health care professionals that assist women
in counteracting the effects of the drug and continuing their pregnancies.
Induced abortion reporting
This bill requires a hospital, clinic, or other facility in which an induced
abortion is performed to report additional information in its required annual report
to DHS. Under current law, the report must include, among other pieces of
information, for each patient, the state, and county if Wisconsin, of residence; certain
demographic information; the month and year in which the abortion was performed;
the number of weeks since the patient's last menstrual period; whether the abortion
was chemically or surgically induced or surgically induced following a failed
chemical abortion; any resulting complications; and certain information for
abortions of an unborn child capable of experiencing pain. This bill adds to the
information required in the report the number of previous induced abortions, if any;
whether the induced abortion was paid for by private health coverage, public
assistance coverage, or self-pay; and the reason for the induced abortion as selected
Sponsors
Introduced by: Bernier (R) , Craig (R) , Darling (R) , Jacque (R) , Kapenga (R) , Kooyenga (R) , LeMahieu (R) , Marklein (R) , Nass (R) , Olsen (R) , Roth (R) , Stroebel (R) , Testin (R) , Tiffany (R) , Wanggaard (R)
37 cosponsors
Allen (R) , Ballweg (R) , Brandtjen (R) , Dittrich (R) , Duchow (R) , Edming (R) , Felzkowski (R) , Gundrum (R) , Horlacher (R) , Hutton (R) , Jagler (R) , James (R) , Katsma (R) , Kerkman (R) , Knodl (R) , Kuglitsch (R) , Kulp (R) , Kurtz (R) , Loudenbeck (R) , Murphy (R) , Oldenburg (R) , Ott (R) , Plumer (R) , Pronschinske (R) , Quinn (R) , Rodriguez (R) , Rohrkaste (R) , Sanfelippo (R) , Schraa (R) , Skowronski (R) , Snyder (R) , Sortwell (R) , Spiros (R) , Thiesfeldt (R) , Tittl (R) , Tusler (R) , Vos (R)
Votes
Senate: Report passage recommended by Committee on Government Operations, Technology and Consumer Protection, Ayes 3, Noes 2
Passed 3–2 May 9, 2019 official source full pageNo individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.
Full history
- Apr 22, 2019 · Senate
Introduced by Senators Kapenga, Bernier, Craig, Darling, Jacque, Kooyenga, LeMahieu, Marklein, Nass, Olsen, Roth, Stroebel, Testin, Tiffany and Wanggaard; cosponsored by Representatives Vos, Allen, Ballweg, Brandtjen, Dittrich, Duchow, Felzkowski, Gundrum, Horlacher, Hutton, Jagler, James, Katsma, Kerkman, Knodl, Kuglitsch, Kulp, Kurtz, Loudenbeck, Murphy, Oldenburg, Ott, Plumer, Pronschinske, Quinn, Rodriguez, Rohrkaste, Sanfelippo, Schraa, Skowronski, Snyder, Sortwell, Spiros, Thiesfeldt, Tittl, Tusler and Edming
- Apr 22, 2019 · Senate
Read first time and referred to Committee on Government Operations, Technology and Consumer Protection
- May 7, 2019 · Senate
Public hearing held
- May 9, 2019 · Senate
Executive action taken
- May 9, 2019 · Senate
Report passage recommended by Committee on Government Operations, Technology and Consumer Protection, Ayes 3, Noes 2
- May 9, 2019 · Senate
Available for scheduling
- May 23, 2019 · Senate
Senate Amendment 1 offered by Senator Jacque
- Apr 1, 2020 · Senate
Failed to pass pursuant to Senate Joint Resolution 1